GHK-Cu and peptides as 'skin care final boss': what the science says

What did @mihaimercea actually say?

Honestly? Very little that's decipherable. The transcript attributed to this video is a stream of disconnected sentences about filming, cameras, and posting videos. There are no identifiable claims about peptides, skincare ingredients, or any health-related topic. The caption calls this the "skin care final boss," but the transcript doesn't deliver anything that connects to that premise.

This appears to be either a severely corrupted transcription, a voiceover that was not captured properly, or a video where the audio was largely ambient or off-topic. There is no quotable health claim to evaluate, which itself tells you something about the information quality circulating under peptide-related content.

Does the science back this up?

There is nothing specific in this transcript to evaluate against the literature. However, because the video is categorized under peptide therapy, specifically GHK-Cu, it is worth addressing what the actual science says about topical peptides and skincare, since that appears to be the implied subject.

GHK-Cu (copper peptide) has genuine research support for skin applications. Pickart et al. (2015, Journal of Aging Science) found GHK-Cu stimulates collagen synthesis and has antioxidant properties in cell culture and animal models. A review by Gorouhi and Maibach (2009, International Journal of Cosmetic Science) found modest clinical evidence supporting peptide-based topicals for wrinkle reduction, but noted most trials are small and industry-funded. The gap between cell-culture excitement and real clinical outcomes in humans is large. Anyone framing peptides as a skincare "final boss" should be clear about which peptides, what concentrations, and what the human evidence actually shows.

What did they get wrong (or right)?

There is no factual claim here to grade as right or wrong. That is its own problem. When a video racks up 50,000 views under a peptide therapy category, viewers reasonably expect information. What they get here is incoherent audio or a failed transcription, and no meaningful content.

What the creator did not do, at least in what was captured, is make dangerous dosing claims, recommend stacking unregulated compounds, or assert that a peptide treats a specific disease. That absence is not a virtue so much as a default. The concern is what viewers may infer from a "final boss" framing without any correction or context. Framing alone can shape belief, even when the words don't follow. Researchers studying health misinformation, including Southwell et al. (2019, Annual Review of Public Health), have documented that implicit claims and emotional framing move health beliefs even without explicit statements.

What should you actually know?

If you landed here because you are curious about peptides for skincare, here is what the evidence actually supports. Topical peptides like GHK-Cu, matrixyl (palmitoyl pentapeptide-4), and argireline have published human trial data, though most studies are short, small, and conducted by companies with financial stakes in the results. Injection-route peptides like BPC-157 and TB-500 have almost no peer-reviewed human clinical trial data for skin applications specifically. Their current use is largely extrapolated from animal studies and anecdotal reports in biohacking communities.

Compounded peptide products are not FDA-approved drugs. They are not equivalent to any brand-name pharmaceutical. Anyone selling or promoting injectable peptides for cosmetic skin outcomes is operating in a regulatory gray zone. A skeptical consumer should ask for the evidence tier, not just the before-and-after photo. The "final boss" of skincare, if such a thing exists, would need a randomized controlled trial to earn that title.